Since its spinoff from Pfizer in 2013, animal healthcare behemoth Zoetis (NYSE: ZTS) has seen its cash from operations nearly quintuple as a stand-alone company. Powered by a diverse array of animal health offerings that serve both the companion animal and livestock industries, Zoetis has become a robust, ...
motleyfoolusx:zts
